Filtros : "ULRICH, ALEXANDER HENNING" "Emirados Árabes Unidos" Limpar

Filtros



Refine with date range


  • Source: Current Medicinal Chemistry. Unidade: IQ

    Subjects: BIOMARCADORES, HIPERTENSÃO, DOENÇAS CARDIOVASCULARES, METABOLÔMICA, GENÔMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIBEIRO, Patrícia de Carvalho et al. Biomarkers in hypertension and hypertension-related disorders. Current Medicinal Chemistry, v. 30, n. 34, p. 3846-3879, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220921113403. Acesso em: 23 ago. 2024.
    • APA

      Ribeiro, P. de C., Oliveira, L. F., Mendes Filho, D., Parreira, R. C., Vieira, M. S., Marques, B. L., et al. (2023). Biomarkers in hypertension and hypertension-related disorders. Current Medicinal Chemistry, 30( 34), 3846-3879. doi:10.2174/0929867329666220921113403
    • NLM

      Ribeiro P de C, Oliveira LF, Mendes Filho D, Parreira RC, Vieira MS, Marques BL, Freitas EM da M, Silva WN, Santiago H da C, Birbrair A, Ulrich H, Silva VJD da, Resende RR. Biomarkers in hypertension and hypertension-related disorders [Internet]. Current Medicinal Chemistry. 2023 ; 30( 34): 3846-3879.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/0929867329666220921113403
    • Vancouver

      Ribeiro P de C, Oliveira LF, Mendes Filho D, Parreira RC, Vieira MS, Marques BL, Freitas EM da M, Silva WN, Santiago H da C, Birbrair A, Ulrich H, Silva VJD da, Resende RR. Biomarkers in hypertension and hypertension-related disorders [Internet]. Current Medicinal Chemistry. 2023 ; 30( 34): 3846-3879.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/0929867329666220921113403
  • Source: Young Perspectives for Old Diseases. Unidade: IQ

    Assunto: DOENÇA DE PARKINSON (GENÉTICA;DIAGNÓSTICO)

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCHWINDT, Telma Tiemi e FERRAZOLI, Enéas Galdini e ULRICH, Henning. Parkinson's disease: genetics, mechanisms and diagnosis. Young Perspectives for Old Diseases. Tradução . Sharjah: Bentham Science, 2015. . . Acesso em: 23 ago. 2024.
    • APA

      Schwindt, T. T., Ferrazoli, E. G., & Ulrich, H. (2015). Parkinson's disease: genetics, mechanisms and diagnosis. In Young Perspectives for Old Diseases. Sharjah: Bentham Science.
    • NLM

      Schwindt TT, Ferrazoli EG, Ulrich H. Parkinson's disease: genetics, mechanisms and diagnosis. In: Young Perspectives for Old Diseases. Sharjah: Bentham Science; 2015. [citado 2024 ago. 23 ]
    • Vancouver

      Schwindt TT, Ferrazoli EG, Ulrich H. Parkinson's disease: genetics, mechanisms and diagnosis. In: Young Perspectives for Old Diseases. Sharjah: Bentham Science; 2015. [citado 2024 ago. 23 ]
  • Source: Central Nervous System Agents in Medicinal Chemistry. Unidade: IQ

    Subjects: ÓXIDO NÍTRICO, NEUROTRANSMISSORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RESENDE, Rodrigo Ribeiro e FARIA, Marcella e ULRICH, Henning. The Contribution of Nitric Oxide and Carbon Monoxide to Neuronal Function and Development. Central Nervous System Agents in Medicinal Chemistry, v. 7, n. 2, p. 85-96, 2007Tradução . . Disponível em: https://doi.org/10.2174/187152407780831666. Acesso em: 23 ago. 2024.
    • APA

      Resende, R. R., Faria, M., & Ulrich, H. (2007). The Contribution of Nitric Oxide and Carbon Monoxide to Neuronal Function and Development. Central Nervous System Agents in Medicinal Chemistry, 7( 2), 85-96. doi:10.2174/187152407780831666
    • NLM

      Resende RR, Faria M, Ulrich H. The Contribution of Nitric Oxide and Carbon Monoxide to Neuronal Function and Development [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2007 ;7( 2): 85-96.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/187152407780831666
    • Vancouver

      Resende RR, Faria M, Ulrich H. The Contribution of Nitric Oxide and Carbon Monoxide to Neuronal Function and Development [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2007 ;7( 2): 85-96.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/187152407780831666
  • Source: Recent Patents on CNS Drug Discovery. Unidade: IQ

    Assunto: DOENÇAS NEURODEGENERATIVAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RESENDE, Rodrigo Ribeiro e ULRICH, Henning e FARIA, Marcella. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, v. 2, n. 1, p. 37-46, 2007Tradução . . Disponível em: https://doi.org/10.2174/157488907779561736. Acesso em: 23 ago. 2024.
    • APA

      Resende, R. R., Ulrich, H., & Faria, M. (2007). Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, 2( 1), 37-46. doi:10.2174/157488907779561736
    • NLM

      Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/157488907779561736
    • Vancouver

      Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/157488907779561736

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024